// App-Quantinova.ai

PB0986 : Surrogate FVIII Activity in Patient and Constructed Plasma Samples Containing Emicizumab: A National External Quality Assurance Scheme for Blood Coagulation (UK NEQAS BC) Exercise

Researchers

Presenter

  • A. Lowe

Principal Investigators

  • I. Jennings

  • S. Kitchen

  • D. Kitchen

  • L. Brown

  • S. Munroe-Peart

  • I. Walker

Medical Centers

  • NEQAS Blood Coagulation, Sheffield, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • N/A

Drug/Treatment

  • FVIII

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved